Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

RTW Biotech Opportunities Ltd

RTW.L ✗ NOT COMPLIANT ☆ Track — members

LSE · Financials · Closed End Funds ·

UK Small Cap Analyst: STRONG BUY

Last Close

$2.58

▼ -1.15%

Market Cap $831.59M · Vol 454.94K

Key Metrics

P/E Ratio

3.38

FWD: N/A

Market Cap

$831.59M

Small Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

65.12

Momentum

Beta

1.23

vs Market

52W High

$2.64

2.27% below

52W Low

$1.38

86.96% above

Volume

454.94K

Avg 256.09K

P/B

0.81

Price-to-book

ROE

N/A

Return on equity

Free Float

83.80%

Public shares

Shariah Compliance8 STANDARDS

✗ RTW Biotech Opportunities Ltd (RTW.L) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RTW.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.79%

+7.05%

+17.81%

+23.44%

YTD

+19.44%

+86.28%

+105.17%

+34.38%

Financials & Valuation

TTM · Annual

Total Revenue	$34.57M
Net Income	$245.19M
Revenue Growth (YoY)	+807.21%
Gross Margin	95.70%
Operating Margin	92.17%
Net Profit Margin	92.17%
ROE	N/A
ROA · ROIC	26.81% · N/A

P/E Ratio	3.38
Forward P/E (FY1)	N/A
PEG Ratio	0.00
P/S	2.65
P/B	0.81
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	322.32M

Technical Indicators

50-Day SMA	$2.39
200-Day SMA	$2.16
RSI (14)	65.12
Beta	1.23
52-Week High	$2.64
52-Week Low	$1.38

Volume Today	454.94K
Avg Daily Volume (30D)	256.09K
Relative Volume	1.78x
Volatility (10D)	22.42
Volatility (30D)	20.30
Free Float	83.80%

Analyst Consensus

STRONG BUY

Current Price $2.58

Mean Target N/A

52W Low$1.38 52W High$2.64

Current

Target

$1.38 $2.64

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG00QKHM560

ISINGG00BKTRRM22

CountryGuernsey

Sub-IndustryClosed End Funds

Earnings DateSep 16, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

Company Profile

RTW Biotech Opportunities Ltd is a Guernsey-based company focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data-driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.